510(k) device
Nelli (Version 7.11)
Neuro Event Labs OY · Physiological Signal Based Seizure Monitoring System (POS, Class II) · First FDA decision Nov 21, 2025, newest Nov 21, 2025Epilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
3
Naming "Nelli"
MAUDE reports
0
Brand "Nelli", since 2015
PubMed studies
20
Mentioning "Nelli"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Nelli (Version 7.11)Breakthrough510(k)
K251506 · Decided Nov 21, 2025 · 189 days after receipt
Device type: Physiological Signal Based Seizure Monitoring System (POS) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Nelli", any status and sponsor, newest update first.
- A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning (USF)Completed
Neuro Event Labs Inc.Not on our public-company list
NCT06705439 · 33 participants · Start Nov 15, 2024 · Primary completion Dec 31, 2025
Device: Nelli · For: Epilepsy
Sites: Tampa, Florida
- A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning - NelliCompleted
Neuro Event Labs Inc.Not on our public-company list
NCT05606575 · 150 participants · Start Aug 1, 2022 · Primary completion Dec 31, 2025
Device: Nelli · For: Epilepsy
Sites: Memphis, Tennessee
Neuro Event Labs Inc.Not on our public-company list
NCT04738552 · 233 participants · Start Jan 9, 2020 · Primary completion Nov 27, 2022
Device: Nelli · For: Epilepsy
Sites: Philadelphia, Pennsylvania
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Nelli", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code POS
4 reports: 2 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Nelli"[tiab]. The summary above synthesizes these.
- Improving nocturnal event monitoring in people with intellectual disability in community using an artificial intelligence camera.
Lennard S, Newman R, McLean B, et al. · Epilepsy Behav Rep · 2023
- Automated detection of nocturnal motor seizures using an audio-video system.
Armand Larsen S, Terney D, Østerkjerhuus T, et al. · Brain Behav · 2022Clinical Trial, Phase III, Research Support, Non-U.S. Gov't
- A Hyper-Heuristic Ensemble Method for Static Job-Shop Scheduling.
Hart E, Sim K · Evol Comput · 2016
- Automatic classification of hyperkinetic, tonic, and tonic-clonic seizures using unsupervised clustering of video signals.
Ojanen P, Kertész C, Morales E, et al. · Front Neurol · 2023
- Clinical utility of a video/audio-based epilepsy monitoring system Nelli.
Basnyat P, Mäkinen J, Saarinen JT, et al. · Epilepsy Behav · 2022
- Video-based automatic seizure detection in pharmacoresistant epilepsy: A prospective exploratory study.
Andersson FK, Gauffin H, Lindehammar H, et al. · Epilepsy Behav · 2024
- Seizure classification using a multimodal seizure monitoring system (Nelli) in Dravet and Lennox-Gastaut syndromes: A non-randomized, single-center feasibility study.
Wilms LK, Lossius MI, Annala K, et al. · Epilepsia · 2026
- Effect of traditional plants in Sri Lanka on skin fibroblast cell number.
Sano K, Someya T, Hara K, et al. · Data Brief · 2018
- Effect of traditional plants in Sri Lanka on skin keratinocyte count.
Sano K, Someya T, Hara K, et al. · Data Brief · 2018
- Update review on SUDEP: Risk assessment, background & seizure detection devices.
Monté CPJA, Arends JBAM, Lazeron RHC, et al. · Epilepsy Behav · 2024Review
- Fibroblast and keratinocyte gene expression following exposure to the extracts of holy basil plant (Ocimum tenuiflorum), malabar nut plant (Justicia adhatoda), and emblic myrobalan plant (Phyllanthus emblica).
Someya T, Sano K, Hara K, et al. · Data Brief · 2018
- Antioxidant activities of traditional plants in Sri Lanka by DPPH free radical-scavenging assay.
Hara K, Someya T, Sano K, et al. · Data Brief · 2018
Other devices of this type
Also filed under product code POS.
- EpiMonitorEmpatica S.r.l. · 510(k) 2025
- SPEAC SystemBrain Sentinel, Inc. · 510(k) 2021
- EmbraceEmpatica S.r.l. · 510(k) 2018
- NightWatch+ USLivassured BV · 510(k) 2025
- EpiWatch Monitoring SystemEpiwatch, Inc. · 510(k) 2025
- CompanionLgch, Inc. · De Novo 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.